TONES automates IHC by coordinating a micro-fluidic staining slot, a precision dosing system (pump block + valve matrix), and smart control software to run your full protocol end-to-end with minimal hands-on time. Reagents are selected from temperature-controlled reservoirs, metered with high accuracy, guided through optimized micro-channels across the tissue, incubated at set temperatures, and then removed—on repeat—until the slide is ready. Under the hood, three hardware modules—staining, automatic reagent handling, and cooling—work under an independent control/software layer that orchestrates the core actions: dosing, incubation, cooling, and waste removal. This architecture is fully documented (process flows, timing charts, interface specs) to guarantee predictable runs and easy validation. The micro-fluidic chip at the heart of the slot is tuned for uniform flow, low reagent use, and bubble prevention, while a self-calibrating in-line level sensor and temperature-controlled storage keep runs reliable and reagents stable.

On the software side, a modular stack with a drag-and-drop protocol builder and live status alerts lets you edit, save, and reuse methods—so you keep scientific control while the robot handles the routine. And because TONES is vendor-agnostic by design, you can run the antibodies, detection kits, and buffers you prefer—no lock-ins. Patent In April 2025, our technology was granted a patent—protecting the system’s integrated approach to precise, programmable IHC automation and its micro-fluidic, sensor-assisted control that drives consistent, reproducible staining with less waste. The patent protection underlines that this isn’t just another autostainer—it’s a distinct, defensible way to run vendor independant IHC with true walk-away reliability. Patenting core technology safeguards innovation and turns it into a defensible advantage—building co